menu search

Why shares of newamsterdam pharma were plummeting on wednesday

NewAmsterdam is a clinical-stage biopharmaceutical company with a lead therapy candidate that lowers ch...

June 7, 2023, 3:55 pm

Intercept (icpt) announces positive data from pbc study

Intercept pharmaceuticals (ICPT) announces new data showing the potential of a fixed-dose combination o...

June 7, 2023, 3:49 pm

Aligos therapeutics to present data on its liver disease programs at the european association for the study of the liver (easl) congress 2023

SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage bio...

June 7, 2023, 11:30 am

Is amphastar pharmaceuticals (amph) stock outpacing its medical peers this year?

Here is how Amphastar pharmaceuticals (AMPH) and Arbutus Biopharma (ABUS) have performed compared to th...

June 7, 2023, 10:48 am

Vertex (vrtx) stock poised well for growth in 2023: here's why

Vertex pharmaceuticals (VRTX) stock is likely to be driven by several catalysts this year. Multiple cli...

June 7, 2023, 10:03 am

Aligos therapeutics to present data on its liver disease programs at the european association for the study of the liver (easl) congress 2023

SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage bio...

June 7, 2023, 7:30 am

Arbutus to present ab-729 and ab-836 data at easl congress 2023

WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage bio...

June 7, 2023, 6:01 am

Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in science advances demonstrating potent in vitro and in vivo antimicrobial activity

Novel antibiotics were developed by Spexis in close collaboration with Professor Oliver Zerbe’s group at the University of Zurich with substantial f...

June 7, 2023, 5:15 am

Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in science advances demonstrating potent in vitro and in vivo antimicrobial activity

Novel antibiotics were developed by Spexis in close collaboration with Professor Oliver Zerbe’s group at the University of Zurich with substantial f...

June 7, 2023, 5:15 am

Day one announces pricing of public offering of common stock

BRISBANE, Calif., June 06, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a...

June 7, 2023, 2:31 am

Arbutus to present ab-729 and ab-836 data at easl congress 2023

WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage bio...

June 7, 2023, 2:01 am

Cymabay therapeutics to present new data highlighting seladelpar's unique activity in patients with primary biliary cholangitis at the international liver congress™ 2023

Two abstracts focus on the unique mechanism of action of seladelpar; a third focuses on characterizing patient risk of PBC disease progression NEWARK,...

June 7, 2023, 2:00 am

Global medical grade coatings market is estimated to be worth us$ 19.8 billion at a cagr of 10% during forecast 2023 to 2033 | future market insights, inc.

Due to the rising demand from the pharmaceutical and medical sectors in the United States, North Americ...

June 6, 2023, 5:30 pm

Dbv technologies to participate in upcoming investor conference

Montrouge, France, June 06, 2023 DB V Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR00104173...

June 6, 2023, 5:00 pm

Xenon pharmaceuticals to present at the goldman sachs 44th annual global healthcare conference

VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Xenon pharmaceuticals Inc. (Nasdaq:XENE)...

June 6, 2023, 4:35 pm

Reata pharmaceuticals announces participation in the goldman sachs 44th annual global healthcare conference

PLANO, Texas--(BUSINESS WIRE)--Reata pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,...

June 6, 2023, 4:31 pm

Terns pharmaceuticals to present at goldman sachs 44th annual global healthcare conference

FOSTER CITY, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Terns pharmaceuticals, Inc. (“Terns” or the ...

June 6, 2023, 4:30 pm

Pmv pharmaceuticals to participate in the goldman sachs global healthcare conference

PRINCETON, N.J., June 06, 2023 (GLOBE NEWSWIRE) -- PMV pharmaceuticals, Inc. (Nasdaq: PMVP), a precisio...

June 6, 2023, 4:01 pm

Agenus is “turning cold tumors hot and making ctla-4 cool again”

Agenus Inc (NASDAQ:AGEN) and its optimized approach on a validated mechanism (CTLA-4) offer a rare investible opportunity in immuno-oncology (IO), wro...

June 6, 2023, 2:22 pm

European patent office to grant zyversa therapeutics’ patent application for cholesterol transport mediator™ var 200 for use in patients with diabetic nephropathy/diabetic kidney disease

Cholesterol Transport Mediator™ VAR 200 is in development to reduce renal cholesterol and lipid accumulation that damages the kidneys’ filtration ...

June 6, 2023, 1:07 pm


Search within

Pages Search Results: